Lipoprotein receptor-related protein 1 regulates collagen 1 expression, proteolysis, and migration in human pleural mesothelial cells

American Journal of Respiratory Cell and Molecular Biology

Volumn 46, Issue 2, 2012, Pages 196-206

  Tucker, Torry A ^a   Williams, LaTerrica ^a   Koenig, Kathleen ^a   Kothari, Hema ^a   Komissarov, Andrey A ^a   Florova, Galina ^a   Mazar, Andrew P ^b   Allen, Timothy C ^a   Bdeir, Khalil ^c   Rao, L Vijaya Mohan ^a   Idell, Steven ^a  

^a UNIVERSITY OF TEXAS HEALTH CENTER   (United States)

^b NORTHWESTERN UNIVERSITY   (United States)

^c UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Half life; Internalization; LRP 1; Pleural mesothelial cells; uPAR

Indexed keywords

COLLAGEN TYPE 1; INTERLEUKIN 1BETA; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN; TUMOR NECROSIS FACTOR ALPHA; UROKINASE RECEPTOR;

ARTICLE; CELL MIGRATION; COLLAGEN SYNTHESIS; CONTROLLED STUDY; DOWN REGULATION; ENZYME ACTIVITY; FIBRINOLYSIS; HUMAN; HUMAN CELL; INTERNALIZATION; MESOTHELIUM CELL; PROTEIN DEGRADATION; PROTEIN EXPRESSION; PROTEIN PROCESSING; PROTEIN STABILITY;

CELL LINE; COLLAGEN TYPE I; EPITHELIUM; HUMANS; PLEURA; PROTEOLYSIS; RECEPTORS, LIPOPROTEIN;

EID: 84856648815     PISSN: 10441549     EISSN: None     Source Type: Journal    
DOI: 10.1165/rcmb.2011-0071OC     Document Type: Article

References (52)

1. Herz J, Strickland DK. Lrp: a multifunctional scavenger and signaling receptor. J Clin Invest 2001;108:779-784. (Pubitemid 32880284)
2. Kounnas MZ, Henkin J, Argraves WS, Strickland DK. Low density lipoprotein receptor-related protein/alpha 2-macroglobulin receptor mediates cellular uptake of pro-urokinase. J Biol Chem 1993;268:21862-21867. (Pubitemid 23320688)
3. Conese M, Blasi F. Urokinase/urokinase receptor system: internalization/ degradation of urokinase-serpin complexes: mechanism and regulation. Biol Chem Hoppe Seyler 1995;376:143-155.
4. Cortese K, Sahores M, Madsen CD, Tacchetti C, Blasi F. Clathrin and lrp-1-independent constitutive endocytosis and recycling of upar. PLoS ONE 2008;3:e3730.
5. Nassar T, Haj-Yehia A, Akkawi S, Kuo A, Bdeir K, Mazar A, Cines DB, Higazi AA. Binding of urokinase to low density lipoprotein-related receptor (lrp) regulates vascular smooth muscle cell contraction. J Biol Chem 2002;277:40499-40504. (Pubitemid 35215627)
6. Teesalu T, Blasi F, Talarico D. Embryo implantation in mouse: fetomaternal coordination in the pattern of expression of upa, upar, pai-1 and alpha 2mr/lrp genes. Mech Dev 1996;56:103-116.
7. Conese M, Nykjaer A, Petersen CM, Cremona O, Pardi R, Andreasen PA, Gliemann J, Christensen EI, Blasi F. Alpha-2 macroglobulin receptor/ldl receptor-related protein(lrp)-dependent internalization of the urokinase receptor. J Cell Biol 1995;131:1609-1622.
8. Nykjaer A, Kjoller L, Cohen RL, Lawrence DA, Garni-Wagner BA, Todd RF III, van Zonneveld AJ, Gliemann J, Andreasen PA. Regions involved in binding of urokinase-type-1 inhibitor complex and pro-urokinase to the endocytic alpha 2-macroglobulin receptor/ low density lipoprotein receptor-related protein: evidence that the urokinase receptor protects pro-urokinase against binding to the endocytic receptor. J Biol Chem 1994;269:25668-25676.
9. Weaver AM, Hussaini IM, Mazar A, Henkin J, Gonias SL. Embryonic fibroblasts that are genetically deficient in low density lipoprotein receptor-related protein demonstrate increased activity of the urokinase receptor system and accelerated migration on vitronectin. J Biol Chem 1997;272:14372-14379. (Pubitemid 27232853)
10. Blasi F. The urokinase receptor and cell migration. Semin Thromb Hemost 1996;22:513-516. (Pubitemid 27107335)
11. Webb DJ, Nguyen DH, Sankovic M, Gonias SL. The very low density lipoprotein receptor regulates urokinase receptor catabolism and breast cancer cell motility in vitro. J Biol Chem 1999;274:7412-7420.
12. Zhang L, Strickland DK, Cines DB, Higazi AA. Regulation of single chain urokinase binding, internalization, and degradation by a plasminogen activator inhibitor 1-derived peptide. J Biol Chem 1997;272:27053-27057. (Pubitemid 27452660)
13. Czekay RP, Kuemmel TA, Orlando RA, Farquhar MG. Direct binding of occupied urokinase receptor (upar) to ldl receptor-related protein is required for endocytosis of upar and regulation of cell surface urokinase activity. Mol Biol Cell 2001;12:1467-1479. (Pubitemid 33044425)
14. Nykjaer A, Conese M, Christensen EI, Olson D, Cremona O, Gliemann J, Blasi F. Recycling of the urokinase receptor upon internalization of the upa:Serpin complexes. EMBO J 1997;16:2610-2620. (Pubitemid 27226200)
15. Shetty S, Idell S. Posttranscriptional regulation of urokinase receptor gene expression in human lung carcinoma and mesothelioma cells in vitro. Mol Cell Biochem 1999;199:189-200. (Pubitemid 29476157)
16. Shetty S, Kumar A, Johnson AR, Pueblitz S, Holiday D, Raghu G, Idell S. Differential expression of the urokinase receptor in fibroblasts from normal and fibrotic human lungs. Am J Respir Cell Mol Biol 1996;15:78-87. (Pubitemid 126439858)
17. Shetty S, Velusamy T, Shetty RS, Marudamuthu AS, Shetty SK, Florova G, Tucker T, Koenig K, Shetty P, Bhandary YP, et al. Posttranscriptional regulation of plasminogen activator inhibitor-1 expression in human pleural mesothelial cells. Am J Respir Cell Mol Biol 2010;43:358-367.
18. Tucker TA, Dean C, Komissarov A, Koenig K, Mazar A, Allen T, Pendurthi U, Idell S. The urokinase receptor supports tumorigenesis of human malignant pleural mesothelioma cells. Am J Respir Cell Mol Biol 2010;42:685-696.
19. Antony VB, Owen CL, Hadley KJ. Pleural mesothelial cells stimulated by asbestos release chemotactic activity for neutrophils in vitro. Am Rev Respir Dis 1989;139:199-206. (Pubitemid 19030445)
20. Bajaj MS, Pendurthi U, Koenig K, Pueblitz S, Idell S. Tissue factor pathway inhibitor expression by human pleural mesothelial and mesothelioma cells. Eur Respir J 2000;15:1069-1078. (Pubitemid 30399277)
21. Idell S, Allen T, Chen S, Koenig K, Mazar A, Azghani A. Intrapleural activation, processing, efficacy, and duration of protection of singlechain urokinase in evolving tetracycline-induced pleural injury in rabbits. Am J Physiol Lung Cell Mol Physiol 2007;292:L25-L32. (Pubitemid 46103427)
22. Tang CH, Hill ML, Brumwell AN, Chapman HA, Wei Y. Signaling through urokinase and urokinase receptor in lung cancer cells requires interactions with beta1 integrins. J Cell Sci 2008;121:3747-3756.
23. Nguyen DH, Hussaini IM, Gonias SL. Binding of urokinase-type plasminogen activator to its receptor in mcf-7 cells activates extracellular signal-regulated kinase 1 and 2 which is required for increased cellular motility. J Biol Chem 1998;273:8502-8507. (Pubitemid 28168915)
24. Owens MW, Grimes SR. Pleural mesothelial cell response to inflammation: tumor necrosis factor-induced mitogenesis and collagen synthesis. Am J Physiol 1993;265:L382-L388.
25. Luttrell IP, Swee M, Starcher B, Parks WC, Chitaley K. Erectile dysfunction in the type ii diabetic db/db mouse: impaired venoocclusion with altered cavernosal vasoreactivity and matrix. Am J Physiol Heart Circ Physiol 2008;294:H2204-H2211.
26. Shetty S, Kumar A, Johnson A, Pueblitz S, Idell S. Urokinase receptor in human malignant mesothelioma cells: role in tumor cell mitogenesis and proteolysis. Am J Physiol 1995;268:L972-L982.
27. Schwab W, Schulze-Tanzil G, Mobasheri A, Dressler J, Kotzsch M, Shakibaei M. Interleukin-1beta-induced expression of the urokinasetype plasminogen activator receptor and its co-localization with mmps in human articular chondrocytes. Histol Histopathol 2004;19:105-112. (Pubitemid 38111254)
28. Campana WM, Li X, Dragojlovic N, Janes J, Gaultier A, Gonias SL. The low-density lipoprotein receptor-related protein is a pro-survival receptor in schwann cells: possible implications in peripheral nerve injury. J Neurosci 2006;26:11197-11207. (Pubitemid 44772207)
29. Noguchi T, Noguchi M, Masubuchi H, Seki T, Ariga T. Il-1beta downregulates tissue-type plasminogen activator by up-regulating lowdensity lipoprotein receptor-related protein in aml 12 cells. Biochem Biophys Res Commun 2001;288:42-48. (Pubitemid 32999722)
30. Goedde MF, Grimbergen JM, Toet KH, Sitter T, Quax PH, Kooistra T. Adenovirus-mediated transfer of the 39 kd receptor-associated protein increases fibrinolytic capacity. Kidney Int 2001;60:117-125. (Pubitemid 32587546)
31. Dedieu S, Langlois B, Devy J, Sid B, Henriet P, Sartelet H, Bellon G, Emonard H, Martiny L. Lrp-1 silencing prevents malignant cell invasion despite increased pericellular proteolytic activities. Mol Cell Biol 2008;28:2980-2995. (Pubitemid 351556530)
32. Ma Z, Thomas KS, Webb DJ, Moravec R, Salicioni AM, Mars WM, Gonias SL. Regulation of rac1 activation by the low density lipoprotein receptor-related protein. J Cell Biol 2002;159:1061-1070. (Pubitemid 36055760)
33. Wang Y, Jones CJ, Dang J, Liang X, Olsen JE, Doe WF. Human urokinase receptor expression is inhibited by amiloride and induced by tumor necrosis factor and phorbol ester in colon cancer cells. FEBS Lett 1994;353:138-142. (Pubitemid 24319814)
34. Goodman RB, Strieter RM, Martin DP, Steinberg KP, Milberg JA, Maunder RJ, Kunkel SL, Walz A, Hudson LD, Martin TR. Inflammatory cytokines in patients with persistence of the acute respiratory distress syndrome. Am J Respir Crit Care Med 1996;154:602-611. (Pubitemid 26327279)
35. Sitter T, Toet K, Quax P, Kooistra T. Fibrinolytic activity of human mesothelial cells is counteracted by rapid uptake of tissue-type plasminogen activator. Kidney Int 1999;55:120-129. (Pubitemid 29004243)
36. Mohanam S, Chandrasekar N, Yanamandra N, Khawar S, Mirza F, Dinh DH, Olivero WC, Rao JS. Modulation of invasive properties of human glioblastoma cells stably expressing amino-terminal fragment of urokinase-type plasminogen activator. Oncogene 2002;21:7824-7830. (Pubitemid 35398840)
37. Schnaper HW, Barnathan ES, Mazar A, Maheshwari S, Ellis S, Cortez SL, Baricos WH, Kleinman HK. Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways. J Cell Physiol 1995;165:107-118.
38. Sitrin RG, Pan PM, Harper HA, Blackwood RA, Todd RF III. Urokinase receptor (cd87) aggregation triggers phosphoinositide hydrolysis and intracellular calcium mobilization in mononuclear phagocytes. J Immunol 1999;163:6193-6200.
39. Li Y, Knisely JM, Lu W, McCormick LM, Wang J, Henkin J, Schwartz AL, Bu G. Low density lipoprotein (ldl) receptor-related protein 1b impairs urokinase receptor regeneration on the cell surface and inhibits cell migration. J Biol Chem 2002;277:42366-42371. (Pubitemid 35257558)
40. Montuori N, Carriero MV, Salzano S, Rossi G, Ragno P. The cleavage of the urokinase receptor regulates its multiple functions. J Biol Chem 2002;277:46932-46939. (Pubitemid 36159197)
41. Resnati M, Pallavicini I, Wang JM, Oppenheim J, Serhan CN, Romano M, Blasi F. The fibrinolytic receptor for urokinase activates the g protein-coupled chemotactic receptor fprl1/lxa4r. Proc Natl Acad Sci USA 2002;99:1359-1364. (Pubitemid 34136498)
42. Bernstein AM, Twining SS, Warejcka DJ, Tall E, Masur SK. Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation. Mol Biol Cell 2007;18:2716-2727. (Pubitemid 47025736)
43. Tarui T, Akakura N, Majumdar M, Andronicos N, Takagi J, Mazar AP, Bdeir K, Kuo A, Yarovoi SV, Cines DB, et al. Direct interaction of the kringle domain of urokinase-type plasminogen activator (upa) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation. Thromb Haemost 2006;95:524-534.
44. Kanse SM, Benzakour O, Kanthou C, Kost C, Lijnen HR, Preissner KT. Induction of vascular smc proliferation by urokinase indicates a novel mechanism of action in vasoproliferative disorders. Arterioscler Thromb Vasc Biol 1997;17:2848-2854. (Pubitemid 28016031)
45. Nieves EC, Manchanda N. A cleavage-resistant urokinase plasminogen activator receptor exhibits dysregulated cell-surface clearance. J Biol Chem 2010;285:12595-12603.
46. Quax PH, Grimbergen JM, Lansink M, Bakker AH, Blatter MC, Belin D, van Hinsbergh VW, Verheijen JH. Binding of human urokinase-type plasminogen activator to its receptor: residues involved in species specificity and binding. Arterioscler Thromb Vasc Biol 1998;18:693-701. (Pubitemid 28267647)
47. Decologne N, Kolb M, Margetts PJ, Menetrier F, Artur Y, Garrido C, Gauldie J, Camus P, Bonniaud P. Tgf-beta1 induces progressive pleural scarring and subpleural fibrosis. J Immunol 2007;179:6043-6051.
48. Liu Q, Mao H, Nie J, Chen W, Yang Q, Dong X, Yu X. Transforming growth factor {beta}1 induces epithelial-mesenchymal transition by activating the jnk-smad3 pathway in rat peritoneal mesothelial cells. Perit Dial Int 2008;28:S88-S95.
49. Nasreen N, Mohammed KA, Mubarak KK, Baz MA, Akindipe OA, Fernandez-Bussy S, Antony VB. Pleural mesothelial cell transformation into myofibroblasts and haptotactic migration in response to tgf-beta1 in vitro. Am J Physiol Lung Cell Mol Physiol 2009;297:L115-L124.
50. Khalil N, Corne S, Whitman C, Yacyshyn H. Plasmin regulates the activation of cell-associated latent tgf-beta 1 secreted by rat alveolar macrophages after in vivo bleomycin injury. Am J Respir Cell Mol Biol 1996;15:252-259. (Pubitemid 126439878)
51. Yee JA, Yan L, Dominguez JC, Allan EH, Martin TJ. Plasminogendependent activation of latent transforming growth factor beta (tgf beta) by growing cultures of osteoblast-like cells. J Cell Physiol 1993;157:528-534. (Pubitemid 23361181)
52. Boucher P, Li WP, Matz RL, Takayama Y, Auwerx J, Anderson RG, Herz J. Lrp1 functions as an atheroprotective integrator of tgfbeta and pdfg signals in the vascular wall: implications for marfan syndrome. PLoS ONE 2007;2:e448.